Preclinical Profile of a Potent γ-Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties
Authors:
- 1 October 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (19) , 7672-7680
Abstract
Notch signaling is an area of great interest in oncology. RO4929097 is a potent and selective inhibitor of γ-secretase, producing inhibitory activity of Notch signaling in tumor cells. The RO4929097 IC50 in cell-free and cellular assays is in the low nanomolar range with >100-fold selectivity with respect to 75 other proteins of various types (receptors, ion channels, and enzymes). RO4929097 inhibits Notch processing in tumor cells as measured by the reduction of intracellular Notch expression by Western blot. This leads to reduced expression of the Notch transcriptional target gene Hes1. RO4929097 does not block tumor cell proliferation or induce apoptosis but instead produces a less transformed, flattened, slower-growing phenotype. RO4929097 is active following oral dosing. Antitumor activity was shown in 7 of 8 xenografts tested on an intermittent or daily schedule in the absence of body weight loss or Notch-related toxicities. Importantly, efficacy is maintained after dosing is terminated. Angiogenesis reverse transcription-PCR array data show reduced expression of several key angiogenic genes. In addition, comparative microarray analysis suggests tumor cell differentiation as an additional mode of action. These preclinical results support evaluation of RO4929097 in clinical studies using an intermittent dosing schedule. A multicenter phase I dose escalation study in oncology is under way. [Cancer Res 2009;69(19):7672–80]Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Notch signaling in bulge stem cells is not required for selection of hair follicle fateDevelopment, 2009
- A Notch updatedJournal of Cell Biology, 2009
- Intramembrane Proteolysis by γ-SecretaseJournal of Biological Chemistry, 2008
- The many facets of Notch ligandsOncogene, 2008
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- A Notch1 Ectodomain Construct Inhibits Endothelial Notch Signaling, Tumor Growth, and AngiogenesisCancer Research, 2008
- Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cellsMicrovascular Research, 2008
- Substrate specificity of γ-secretase and other intramembrane proteasesCellular and Molecular Life Sciences, 2008
- IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary glandJournal of Clinical Investigation, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005